The risks and benefits of marijuana have been the subject of vigorous debate for many years. The observational study by Fuster et al.1 provides us with some insight into the risks, or lack thereof. The researchers studied a cohort of 589 primary care patients who screened positive for recent illicit or nonmedical prescription drug use. As would be expected, marijuana was the most commonly used drug, with 84 % reporting use in the past 3 months—almost one-third of these users reported daily use. The researchers found no association between marijuana use and hospitalization, emergency department utilization or quality of life.
Aside from the usual limitations of observational research, the biggest problem with this study was that it included only drug users and did not include a comparison group of non-users. Nevertheless, it raises questions about the harms of marijuana use, particularly among individuals who use other drugs. Previous research has largely failed to find significant harms from marijuana use.2,3 The most concerning findings to date have been associations between marijuana use among youth and subsequent psychotic illness,4 and between acute use and motor vehicle collisions.5 While the Federal Government classifies marijuana as a high-risk substance, it is clear that the risks associated with its use are less than the two most commonly used (and legal) substances: alcohol and tobacco.
How should clinicians use this information? When assessing a patient who uses marijuana, it is probably best to use a patient-centered approach. Blanket statements condemning its use or exaggerated claims regarding harms are unlikely to have any effect and only serve to reduce clinician’s credibility. It is reasonable to counsel younger users on the risks of psychotic illness and to warn drivers on the risk of collisions when under the influence. For others, it is probably best to assess the effect marijuana use has on their lives and to focus our efforts on those who show evidence of harm.
Acknowledgments
Conflict of Interest
The author declares that he/she does not have a conflict of interest.
REFERENCES
- 1.Fuster D, Chang DM, Allensworth-Davies D, Palfai TP, Samet JH, Saitz R. No detectable association between frequency of marijuana use and health or healthcare utilization among primary care patients who screen positive for drug use. J Gen Intern Med. doi:10.1007/s11606-013-2605-z. [DOI] [PMC free article] [PubMed]
- 2.Calabria B, Degenhardt L, Hall W, Lynskey M. Does cannabis use increase the risk of death? Systematic review of epidemiological evidence on adverse effects of cannabis use. Drug Alcohol Rev. 2010;29(3):318–30. doi: 10.1111/j.1465-3362.2009.00149.x. [DOI] [PubMed] [Google Scholar]
- 3.Macleod J, Oakes R, Copello A, et al. Psychological and social sequelae of cannabis and other illicit drug use by young people: a systematic review of longitudinal, general population studies. Lancet. 2004;363:1579–88. doi: 10.1016/S0140-6736(04)16200-4. [DOI] [PubMed] [Google Scholar]
- 4.Large M, Sharma S, Compton MT, Slade T, Nielssen O. Cannabis use and earlier onset of psychosis: a systematic meta-analysis. Arch Gen Psych. 2011;68:555–561. doi: 10.1001/archgenpsychiatry.2011.5. [DOI] [PubMed] [Google Scholar]
- 5.Asbridge M, Hayden JA, Cartwright JL. Acute cannabis consumption and motor vehicle collision risk: systematic review of observational studies. BMJ. 2012;344:e536. doi: 10.1136/bmj.e536. [DOI] [PMC free article] [PubMed] [Google Scholar]